Founding partner

Founding partner

About the Company

Pioneering a new era in mental health by developing the world’s first blood-based biomarker test for anxiety

Industry

Mental Health Care

Type

Privately Held

Founded

2021

Employees

1-10

About the Role

Introducing the World’s First Blood Test to Objectively Measure Anxiety

Stress and anxiety are not merely “in your head”—they trigger measurable physiological changes. Yet, diagnosis remains largely subjective, relying on self-reported questionnaires, despite affecting over 300 million people globally (WHO).

We’ve pioneered the world’s first blood-based biomarker test that objectively quantifies anxiety levels—delivering a scientific, scalable solution for early detection, ongoing monitoring, and targeted intervention.

Mental health costs the global economy $1 trillion annually in lost productivity, yet only one in three individuals with anxiety receives timely care. There is an urgent global need for preventive, data-driven tools.

We are seeking strategic partners and collaborators—including academic institutions, leading universities, research hospitals, public health agencies, and visionary investors—to co-validate and refine our biomarker panel, integrate it into clinical trials and wellness programs, and help scale this breakthrough worldwide.

Together, we can establish a new standard for mental health measurement—enabling precision care through objective data and accelerating research with real-world impact.

This is more than a diagnostic tool—it’s a transformative step toward actionable, science-based mental healthcare.

THIS IS AN EQUITY BASED ROLE

Travel Percent

Less than 10%

Functions

• Business Development
• CEO / President
• Finance
• Venture Capital
• Private Equity

Skills